The emergence of HIV drug resistance (HIVDR) is an Background: unavoidable consequence of antiretroviral therapy (ART), and HIVDR early warning indicators (EWIs) could specifically assess factors at individual clinics associated with HIVDR.
Although Vietnam is among the most-at-risk countries for HIV 1 , the government has responded to HIV epidemics. As of December 2011, there was a total of 318 antiretroviral (ARV) treatment facilities nationwide, including 287 outpatient clinics (OPCs) for adults and 118 ARV treatment facilities for children. The total number of HIV infections treated with ARV was increased to 600, an increase of 25 times compared to the end of 2005 3, 4 .
According to the national plan regarding preventing and monitoring HIV drug resistance (HIVDR) in 2008-2012, Vietnam collects early warning indicators (EWIs) for HIVDR annually. This important activity not only contributes to the prevention and monitoring of HIVDR, but also supports the usage of available data to monitor and evaluate HIV/AIDS care and treatment programs, in order to improve the quality of service delivery. Within the framework of the Global Fund supported project on HIV/AIDS, we conducted this study to interpret results after collecting HIVDR EWIs at 42 HIV/AIDS treatment facilities in 25 northern provinces of Vietnam in 2012. The results of this study evaluate HIV/AIDS treatment effectiveness based on care and treatment national indicators. . EWI data was extracted by the research team using a data collection form that was developed by VAAC (Supplementary File 1). HIV drug resistance EWIs collected in the present study, from the OPCs, included: percentage of patients that were prescribed the correct regimen when starting ART treatment; percentage of ART patients that were lost to follow-up after 12 months; percentage of patients that arrived on time for a doctor's appointment; and percentage of patients that retained first-line ART after 12 months of treatment. 
Methods

Study design and settings
Statistical analysis
Ethical approval
The study received ethical approval from VAAC, Ministry of Health. Data collection procedures and the use of data for analysis were also approved by the directors of the OPCs. No personal patient data was collected in this study.
Results
Table 1 describes EWIs in 42 HIV/AIDs facilities in 2012.
Regarding the availability of antiretroviral drugs, EWIs for HIVDR showed that 7/42 facilities did not reach the target of patients receiving prescriptions for ART, congruent with national guidelines 5 . Regarding patients that abandoned ART treatment after 12 months, only Cao Bang Hospital had a relatively high proportion (15.79%). All facilities (100%) reached the target of <20% of patients lost to follow-up after 12 months of treatment.
Some facilities had very low rate of patients arriving on time for appointments, such as Pho Yen, Thai Nguyen, Cao Loc -Lang Son (Table 2) . Data regarding patient appointments could not be collected at Quang Yen Hospital, Quang Ninh, because this hospital did not make appointments with patients. Regarding the rate of patients retaining on a first line ARV regimen after 12 months of treatment, only a few facilities did not achieve its objectives, including Dai Tu, Thai Nguyen, Hung Yen provincial AIDS center, Thanh Hoa hospital. Dataset 1. Raw data used in the construction of Table 1 and  Table 2 http://dx.doi.org/10.5256/f1000research.11010.d157508
Datasets from early warning indicator systems detailing number of patients starting ART; number of patients in cohort; number of patients lost to follow-up; number of patients retaining ART treatment; number of patients receiving correct regime; number of patients having appointments in last quarter of 2011; and number of patients keeping appointments. on-time. Several implications are drawn from this study. First, since the data about EWIs could be used to optimize the ART program 6 , based on the result of this study, clinics that have a low performance should identify their weaknesses and find corresponding solutions to improve their services. Second, several achievements that were reported in this study should be maintained by the OPCS, including maintaining that all patients receive correct ARV regimens on admission, and continuing a patient roll-out rate of ≤20%. Third, health care providers in ARV facilities should ensure that there are no ARV drug shortages in order that patients are sufficiently provided. It is important to ensure a minimum of 80% of patients receive ARV drugs as scheduled 4 . This could be performed by enhancing outpatient records to track medication dispensing history. Finally, all facilities should regularly review treatment-related data regarding treatment monitoring and EWIs of HIVDR, and issuing data collection activity of HIVDR EWIs should become a routine activity in clinics. Health care providers should address the reasons patients dropped out of treatment regimens, and why patients did not come to follow-up appointments. This could help to improve the quality of service delivery and optimize the benefits of ARV treatment.
Conclusions
Our study suggests that all outcomes measured in the OPCs reached standard goals, according to national guidelines. These remarkable achievements should be maintained. In addition, other considerations should be addressed, including the roll-out rate, the follow-up rate, and the rate of first line retention after 12-month ARV treatment.
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